Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES

Transfusion

Volumn 54, Issue 3, 2014, Pages 602-612

  Sandgren, Per ^a   Meinke, Stephan ^a   Eckert, Elias ^a   Douagi, Iyadh ^a   Wikman, Agneta ^a   Höglund, Petter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; RANTES;

ARTICLE; CELL SURFACE; IMMUNOMODULATION; PLASMA; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CD40 LIGAND; CHEMOKINE CCL5; HUMANS; IMMUNOMODULATION; PLATELET ACTIVATION;

EID: 84896028111     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12345     Document Type: Article

References (46)

1. Muylle L, Peetermans ME,. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994; 66: 14-17.
2. Muylle L, Wouters E, Peetermans ME,. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996; 36: 886-890.
3. Wadhwa M, Seghatchian MJ, Dilger P, Sands D, Krailadisiri P, Contreras M, Thorpe R,. Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion 2000; 40: 1118-1126.
4. Kluter H, Bubel S, Kirchner H, Wilhelm D,. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39: 1179-1184.
5. Bubel S, Wilhelm D, Entelmann M, Kirchner H, Klüter H,. Chemokines in stored platelet concentrates. Transfusion 1996; 36: 445-449.
6. Fujihara M, Ikebuchi K, Wakamoto S, Sekiguchi S,. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999; 39: 498-505.
7. Sandgren P, Hansson M, Gulliksson H, Shanwell A,. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007; 93: 27-36.
8. Sandgren P, Shanwell A, Gulliksson H,. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C. Transfusion 2006; 46: 828-834.
9. Shanwell A, Falker C, Gulliksson H,. Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage. Vox Sang 2003; 85: 206-212.
10. Vo TD, Cowles J, Heal JM, Blumberg N,. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med 2001; 11: 45-47.
11. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL,. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997; 272: 32401-32410.
12. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O,. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46: 1184-1189.
13. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA,. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594.
14. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC,. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-2462.
15. Phipps RP, Kaufman J, Blumberg N,. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001; 357: 2023-2024.
16. Phipps RP, Koumas L, Leung E, Reddy SY, Blieden T, Kaufman J,. The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Investig Drugs 2001; 2: 773-777.
17. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS,. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 2007; 40: 1-16.
18. Winkles JA,. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 2008; 7: 411-425.
19. Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B, Woehrl S, Moritz K, Eiwegger T, Schmid-Grendelmeier P, Kemeny L, Akdis CA,. TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 2011; 127: 200-207. 207 e1-10.
20. Song A, Chen YF, Thamatrakoln K, Storm TA, Krensky AM,. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 1999; 10: 93-103.
21. Uchide N, Ohyama K, Bessho T, Takeichi M, Toyoda H,. Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection. Mediators Inflamm 2012; 2012: 270670.
22. Larsson S, Sandgren P, Sjodin A, Vesterinen M, Gulliksson H,. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 2005; 45: 743-751.
23. Sandgren P, Saeed K,. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit. Blood Transfus 2011; 9: 182-188.
24. Bertolini F, Murphy S,. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1996; 36: 128-132.
25. Moroff G, Eich J, Dabay M,. Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion 1994; 34: 35-38.
26. VandenBroeke T, Dumont LJ, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon JP, Gulliksson H, Dengler T, Hornsey V, Prowse C,; Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang 2004; 86: 183-188.
27. Lundin A,. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol 2000; 305: 346-370.
28. Vanderlinde RE,. Measurement of total lactate dehydrogenase activity. Ann Clin Lab Sci 1985; 15: 13-31.
29. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL,. Platelets and shear stress. Blood 1996; 88: 1525-1541.
30. Shattil SJ, Hoxie JA, Cunningham M, Brass LF,. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114.
31. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE,. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78: 661-669.
32. Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H,. Blood platelet biochemistry. Thromb Res 2012; 129: 245-249.
33. Daugirdas JT, Bernardo AA,. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int 2012; 82: 147-157.
34. Ali SF,. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods. Transfus Apher Sci 2011; 44: 11-13.
35. Gulliksson H,. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003; 17: 209-215.
36. Sandgren P, Hild M, Sjodin A, Gulliksson H,. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang 2010; 99: 341-347.
37. Gawaz M, Ott I, Reininger AJ, Neumann FJ,. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 1994; 72: 912-918.
38. Gulliksson H, AuBuchon JP, Vesterinen M, Sandgren P, Larsson S, Pickard CA, Herschel I, Roger J, Tracy JE, Langweiler M,; Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82: 131-136.
39. Rogers AB, Des Prez RM,. The effect of pH on human platelet aggregation induced by epinephrine and ADP. Proc Soc Exp Biol Med 1972; 139: 1100-1103.
40. Sahler J, Spinelli S, Phipps R, Blumberg N,. CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol 2012; 19: 98-103.
41. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O,. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006; 46: 800-810.
42. Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, Kasai M, Sawada K, Kobayashi R, Kudoh T, Ikebuchi K, Azuma H, Ikeda H,. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003; 43: 1038-1046.
43. Savage WJ, Savage JH, Tobian AA, Thoburn C, Hamilton RG, Schroeder JT, Ness PM,. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012; 52: 575-581.
44. Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM,. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011; 51: 1716-1722.
45. Savage WJ, Tobian AA, Savage JH, Wood RA, Schroeder JT, Ness PM,. Scratching the surface of allergic transfusion reactions. Transfusion 2012; 53: 1361-1371.
46. Ostrowski SR, Bochsen L, Windelov NA, Salado-Jimena JA, Reynaerts I, Goodrich RP, Johansson PI,. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2011; 51: 344-356.